BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20382201)

  • 1. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice.
    Dluzen DE; Ji J; McDermott JL
    Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice.
    Ji J; Dluzen DE
    J Neural Transm (Vienna); 2008 Jun; 115(6):809-17. PubMed ID: 18197357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems.
    Ji J; Bourque M; Di Paolo T; Dluzen DE
    Biochem Pharmacol; 2009 Dec; 78(11):1401-11. PubMed ID: 19615345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice.
    Dluzen DE; McDermott JL; Anderson LI; Kucera J; Joyce JN; Osredkar T; Walro JM
    Neuroscience; 2004; 128(1):201-8. PubMed ID: 15450367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and sex differences in striatal dopaminergic function.
    McDermott JL; Dluzen DE
    Neuroscience; 2007 Oct; 149(2):401-8. PubMed ID: 17900817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S; Morissette M; Morin N; Di Paolo T
    J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice.
    Dluzen DE; Gao X; Story GM; Anderson LI; Kucera J; Walro JM
    Exp Neurol; 2001 Jul; 170(1):121-8. PubMed ID: 11421589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter function differences between male and female CD-1 mice.
    Bhatt SD; Dluzen DE
    Brain Res; 2005 Feb; 1035(2):188-95. PubMed ID: 15722058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system.
    Dluzen DE; Mickley KR
    Pharmacol Biochem Behav; 2005 Jan; 80(1):27-33. PubMed ID: 15652377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in dopamine- and vesicular monoamine-transporter functions.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
    Ren JP; Zhao YW; Sun XJ
    Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice.
    Airavaara M; Planken A; Gäddnäs H; Piepponen TP; Saarma M; Ahtee L
    Eur J Neurosci; 2004 Nov; 20(9):2336-44. PubMed ID: 15525275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system.
    Karakaya S; Kipp M; Beyer C
    J Neuroendocrinol; 2007 Sep; 19(9):682-90. PubMed ID: 17680883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine output is compromised within +/- BDNF mice.
    Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM
    Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.